Cytokeratin Expression and Hyaluronic Acid Production in Cultures of Human Synovial Microvascular Endothelial Cells: Influence of Cytokines and Growth Factors

Microcirculation

Volumn 3, Issue 4, 1996, Pages 359-370

  Carley, William W ^a   Szczepanski, Andrew ^a   Gerritsen, Mary E ^a  

^a BAYER CORPORATION   (United States)

Author keywords

Cytokeratin; Endothelium; Hyaluronate; Synovium

Indexed keywords

ULEX;

BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; CYTOKINE; ENG PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 1; FLUORESCENT DYE; GROWTH PROMOTOR; HYALURONIC ACID; INTERLEUKIN 1; KERATIN; LEUKOCYTE ANTIGEN; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; METABOLISM; MICROCIRCULATION; MIDDLE AGED; SYNOVIUM; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 1; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; GROWTH SUBSTANCES; HUMANS; HYALURONIC ACID; INTERLEUKIN-1; KERATINS; LIPOPROTEINS, LDL; MICROCIRCULATION; MIDDLE AGED; RECEPTORS, CELL SURFACE; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VON WILLEBRAND FACTOR;

EID: 0030320642     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.3109/10739689609148308     Document Type: Article

References (48)

1. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. (1990). CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 3103-3113.
2. Åsheim Å, Linblad G. (1976). Intra-articular treatment of arthritis in race-horses with sodium hyaluronate. Acta Vet Scand 17: 379-394.
3. Ausprunk DH. (1986). Distribution of hyaluronic acid and sulfate glycosaminoglycans during blood vessel development in the chick chorioallantoic membrane. Am J Anat 177: 313-331.
4. Ausprunk DH, Boudrequ CL, Nelson DA. (1981). Proteoglycans in the microvasculature. II. Histochemical localization in proliferating capillaries of the rabbit cornea. Am J Pathol 103: 367-375.
5. Balazs EA, Darzynkiewicz Z. (1993). The effect of hyaluronic acid on fibroblasts, mononuclear phagocytes and lymphocytes. In Biology of Fibroblasts (Eds. Kulonen E, Pikkarainen J), Academic Press, New York, pp. 237-252.
6. Bitter T, Muir H. (1962). A modified uronic acid carbazole reaction. Anal Biochem 4: 330-334.
7. Bonifas JM, Rothman AL, Epstein EH. (1991). Epidermolysis bullosa simplex - evidence in two families for keratin gene abnormalities. Science 254: 1202-1205.
8. Borg AA, Dawes PT, Mattey DL. (1993). Increased levels of IgA antibodies to cytokeratin 18 and epidermal keratin in rheumatoid arthritis. Arthritis Rheum 36: 229-233.
9. Brandt K. (1974). The effect of synovial hyaluronate on the ingestion of monosodium urate crystals by leukocytes. Clin Chem Acta 55: 307-315.
10. Brandt KL, (1970). Modification of chemotaxis by synovial fluid hyaluronate. Arthritis Rheum 13: 308-309.
11. Capetanaki Y, Kuisk I, Rothblum K, Stames S. (1990). Mouse vimentin: structural relationship to fos, jun, CREB and tpr. Oncogene 15: 645-655.
12. Coulombe PA, Hutton ME, Letai A, Hebert A, Paller AS, Fuchs E. (1991). Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analysis. Cell 66: 1301-1311.
13. Dahl LB, Dahl IMS, Engstöm-Laurent A, Granath K. (1985). Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44: 817-822.
14. Demaziere A, Athanasore NA. (1992). Adhesion receptors of intimal and subintimal cells of the normal synovial membrane. J Pathol 168: 209-215.
15. Denning SM, Le PT, Singer KH, Haynes BF. (1990). Antibodies against the CD44 p80 lymphocyte homing receptor molecule augment peripheral blood T-cell activation. J Immunol 144: 7-15.
16. Dodge AB, Patton WF, Moon MU, Hechtman HB, Shepro D. (1991). Organ and species specific differences in cytoskeletal protein profiles of cultured microvascular endothelial cells. Comp Biochem Physiol 98B: 461-470.
17. Engström-Laurent A, Hällgreen R. (1987). Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients: relationship to synovitis mass and morning stiffness. Arthritis Rheum 30: 1333-1338.
18. Farnsdale RW, Sayers CA, Barret AJ. (1993). A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9: 247-248.
19. Forrester JV, Lackie JM. (1991). Effect of hyaluronic acid on neutrophil adhesion. J Cell Sci 50: 329-344.
20. Garrod DR. (1985). The adhesions of epithelial cells. In Cellular and Molecular Control of Direct Cell Interactions (Ed. Marthy HJ), Plenum Press, New York, pp. 43-83.
21. Geiger B. (1987). Intermediate filaments: looking for a function. Nature 329: 292-293.
22. Gerritsen ME, Bloor CM. (1993). Endothelial cell gene regulation in response to injury. FASEB J 7: 423-532.
23. Gerritsen ME, Kelley KA, Ligon G, Perry CA, Shen C-P, Szezepanski A, Carley WW. (1993). Regulation of the expression of intercellular adhesion molecule 1 in cultured human endothelial cells derived from rheumatoid synovium. Arthritis Rheum 36: 593-602.
24. Gordon PB, Conn G, Hatcher VB. (1985). Glycosaminoglycan production in cultures of early and late passage human endothelial cells: the influence of an anionic endothelial cell growth factor and the extracellular matrix. J Cell Physiol 125: 596-607.
25. Green SJ, Tarone G, Underhill CB. (1990). Distribution of hyaluronate and hyaluronate receptors in the adult lung. J Cell Sci 90: 145-156.
26. Hale LP, Martin ME, McCollum DE, Nunley JE, Springer TA, Singer KH, Haynes BF. (1989). Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum 32: 22-30.
27. Hay ED. (1981). Extracellular matrix. J Cell Biol 9: 205s-223s.
28. Haynes BF, Hale LP, Patton KL, Martin ME, McCallum RM. (1991). Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Arthritis Rheum 34: 1434-1443.
29. Iwata H. (1993). Pharmacologic and clinical aspects of intraarticular injection of hyaluronate. Clin Orthop 89: 285-291.
30. Jahn L, Fouquet B, Rohe K, Franke WW. (1987). Cytokeratins in certain endothelial and smooth muscle cells of two taxonomically distinct vertebrate species, Xenopus laevis and man. Differentiation 36: 234-254.
31. Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ. (1991). Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 64: 313-320.
32. Kasper M, Stosiek P, Karsten U. (1988). Coexpression of cytokeratins and vimentin in hyaluronic acid-rich tissues. Acta Histochem 84: 107-108.
33. Lesley H, Hyman R. (1990). CD44 can be activated to function as a hyaluronic acid receptor in normal murine T cells. Eur J Immunol 22: 2719-2723.
34. Levick JR. (1995). Microvascular architecture and exchange in synovial joints. Microcirculation 2: 217-233.
35. Mattey DL, Nixon N, Wynn Hones C, Dawes PT. (1993). Demonstration of cytokeratin in endothelial cells of the synovial microvasculature in situ and in vitro. Br J Rheumatol 32: 676-682.
36. Miossec P, Youinai P, Le Goff P, Moineau MP. (1982). Clinical relevance of anti-keratin antibodies in rheumatoid arthritis. Clin Rheumatol 1: 185-189.
37. Miyake K, Underhill CB, Leslie J, Kincade PJ. (1990). Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69-75.
38. Mineau-Hanschke R, Patton WF, Hechtman HB, Shepro D. (1993). Immunolocalization of cytokeratin 19 in bovine and human pulmonary microvascular endothelial cells in situ. Comp Biochem Physiol 104A: 313-319.
39. Montesano R, Mossaz A, Ryser JE, Orci L, Vassali P. (1984). Leukocyte interleukins induce cultured endothelial cells to produce a highly organized glycosaminoglycanrich pericellular matrix. J Cell Biol 99: 1706-1715.
40. Myer FA, Yaron I, Yaron M. (1990). Synergistic additive and antagonistic effects of interleukin-1β, tumor necrosis factor α and γ interferon on prostaglandin E, hyaluronic acid and collagenase production by human synovial fibroblasts. Arthritis Rheum 33: 1518-1525.
41. Picker LJ, Butcher EC. (1992). Physiological and molecular mechanisms of lymphocyte homing. Ann Rev Immunol 10: 561-591.
42. Ropes MW. (1959). Diagnostic criteria for rheumatoid arthritis: 1958 revision. Ann Rheum Dis 18: 49-54.
43. Stosiek VP, Kasper M, Conrad K. (1990). Immunohistochemische untersuchungen zur cytokeratin-expression in menschlichen gefasendothelien unter besonderer berucksichtigung des gelenkbindegewebes. Acta Histochem 89: 61-66.
44. Sunderland GA, Bulmer JN, Lunscomb M, Redman CWG, Steirrat GM. (1985). Immunohistological and biochemical evidence for a role for hyaluronic acid in the growth and development of the placenta. J Reprod Immunol 8: 197-212.
45. Tobetto K, Nakai K, Akatsuka M, Yasui T, Hirano S. (1993). Inhibitory effects of hyaluronan on neutrophil mediated cartilage degradation. Connect Tissue Res 29: 181-190.
46. Voyta JC, Via DP, Butterfield CE, Zetter BR. (1984). Identification and isolation of endothelial cells based on their increased uptake of acetylated low density lipoprotein. J Cell Biol 99: 2034-2040.
47. Yaron I, Meyer FA, Dayer J-M, Bleiberg I, Yaron M. (1989). Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum 32: 173-180.
48. Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ. (1979). Anti-keratin antibodies in rheumatoid arthritis. Br Med J (Clin Res) 2: 97-99.